Article (Scientific journals)
Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly.
Coopmans, Eva C.; Korevaar, Tim I. M.; van Meyel, Sebastiaan W. F. et al.
2020In Journal of Clinical Endocrinology and Metabolism, 105 (9)
Peer reviewed
 

Files


Full Text
Manuscript_Coopmans_JCEM SRL accepted.pdf
Author preprint (215 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
acromegaly; biochemical response; first-generation somatostatin receptor ligands
Abstract :
[en] CONTEXT: First-generation somatostatin receptor ligands (fg-SRLs) represent the mainstay of medical therapy for acromegaly, but they provide biochemical control of disease in only a subset of patients. Various pretreatment biomarkers might affect biochemical response to fg-SRLs. OBJECTIVE: To identify clinical predictors of the biochemical response to fg-SRLs monotherapy defined as biochemical response (insulin-like growth factor (IGF)-1 ≤ 1.3 × ULN (upper limit of normal)), partial response (>20% relative IGF-1 reduction without normalization), and nonresponse (≤20% relative IGF-1 reduction), and IGF-1 reduction. DESIGN: Retrospective multicenter study. SETTING: Eight participating European centers. METHODS: We performed a meta-analysis of participant data from 2 cohorts (Rotterdam and Liège acromegaly survey, 622 out of 3520 patients). Multivariable regression models were used to identify predictors of biochemical response to fg-SRL monotherapy. RESULTS: Lower IGF-1 concentration at baseline (odds ratio (OR) = 0.82, 95% confidence interval (CI) 0.72-0.95 IGF-1 ULN, P = .0073) and lower bodyweight (OR = 0.99, 95% CI 0.98-0.99 kg, P = .038) were associated with biochemical response. Higher IGF-1 concentration at baseline (OR = 1.40, (1.19-1.65) IGF-1 ULN, P ≤ .0001), the presence of type 2 diabetes (oral medication OR = 2.48, (1.43-4.29), P = .0013; insulin therapy OR = 2.65, (1.02-6.70), P = .045), and higher bodyweight (OR = 1.02, (1.01-1.04) kg, P = .0023) were associated with achieving partial response. Younger patients at diagnosis are more likely to achieve nonresponse (OR = 0.96, (0.94-0.99) year, P = .0070). Baseline IGF-1 and growth hormone concentration at diagnosis were associated with absolute IGF-1 reduction (β = 0.90, standard error (SE) = 0.02, P ≤ .0001 and β  = 0.002, SE = 0.001, P = .014, respectively). CONCLUSION: Baseline IGF-1 concentration was the best predictor of biochemical response to fg-SRL, followed by bodyweight, while younger patients were more likely to achieve nonresponse.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Coopmans, Eva C.
Korevaar, Tim I. M.
van Meyel, Sebastiaan W. F.
Daly, Adrian  ;  Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Chanson, Philippe
Brue, Thierry
Delemer, Brigitte
Hána, Václav
Colao, Annamaria
Carvalho, Davide
Jaffrain-Rea, Marie-Lise
Stalla, Günter K.
Fajardo-Montañana, Carmen
Beckers, Albert ;  Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
van der Lely, Aart J.
Petrossians, Patrick  ;  Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Neggers, Sebastian J. C. M. M.
More authors (7 more) Less
Language :
English
Title :
Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly.
Publication date :
2020
Journal title :
Journal of Clinical Endocrinology and Metabolism
ISSN :
0021-972X
eISSN :
1945-7197
Volume :
105
Issue :
9
Peer reviewed :
Peer reviewed
Commentary :
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Available on ORBi :
since 07 August 2020

Statistics


Number of views
54 (5 by ULiège)
Number of downloads
4 (3 by ULiège)

Scopus citations®
 
23
Scopus citations®
without self-citations
21
OpenCitations
 
16

Bibliography


Similar publications



Contact ORBi